IP Library Granted Patent US 9,914,967
Granted Patent B2
US 9,914,967 · App. 14/402,795 · Granted Mar 13, 2018

Spatial sequencing of nucleic acids using DNA origami probes

Inventors: George M. Church (Brookline, MA); Richard C. Terry (Carlisle, MA); Frederic Vigneault (Natick, MA)
Assignee: President and Fellows of Harvard College
C12Q1/6874C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,914,967
App. No.
14/402,795
Granted
Mar 13, 2018
Kind
B2
Abstract

A method of sequencing nucleic acids by probe hybridization and/or ligation is provided using DNA origami as a barcode for a nucleic acid probe.

Claims (91)

1. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

imaging the single stranded nucleic acid having an oligonucleotide probe hybridized thereto, wherein the oligonucleotide probe is ligated to a sequencing primer hybridized to the single stranded nucleic acid, wherein the oligonucleotide probe includes a spatially distinct nucleic acid structure corresponding to one or more nucleotides in the oligonucleotide probe, wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure, and

identifying the spatially distinct nucleic acid structure, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

2. The method of claim 1 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

3. The method of claim 1 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

4. The method of claim 1 wherein the spatially distinct nucleic acid structure comprises one or more detectable moieties or barcodes.

5. The method of claim 4 wherein the detectable moieties or barcodes correspond to the one or more nucleotides in the oligonucleotide probe.

6. The method of claim 4 wherein the detectable moieties or barcodes comprise fluorescent moieties.

7. The method of claim 1 wherein the spatially distinct nucleic acid structure comprises a substantially circular structure.

8. The method of claim 1 wherein the spatially distinct nucleic acid structure is attached to the one or more nucleotides in the oligonucleotide probe via a linker.

9. The method of claim 1 wherein the spatially distinct nucleic acid structure is coupled to the one or more nucleotides in the oligonucleotide probe by a cleavable nucleotide.

10. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

imaging the single stranded nucleic acid having an oligonucleotide probe hybridized thereto, wherein the oligonucleotide probe includes a spatially distinct nucleic acid structure corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure, and

identifying the spatially distinct nucleic acid structure, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid,

wherein the single stranded nucleic acid has a plurality of oligonucleotide probes hybridized thereto and wherein each spatially distinct nucleic acid structure, the one or more corresponding nucleotides in the oligonucleotide probe and the one or more complementary nucleotides in the single stranded nucleic acid are identified.

11. The method of claim 10 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and 100 hybridizable nucleotides.

12. The method of claim 10 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe, and wherein the detectable label is detected.

13. The method of claim 10 wherein the spatially distinct nucleic acid structure comprises one or more detectable moieties or barcodes.

14. The method of claim 13 wherein the detectable moieties or barcodes correspond to the one or more nucleotides in the oligonucleotide probe.

15. The method of claim 13 wherein the detectable moieties or barcodes comprise fluorescent moieties.

16. The method of claim 10 wherein the spatially distinct nucleic acid structure comprises a substantially circular structure.

17. The method of claim 10 wherein the spatially distinct nucleic acid structure is attached to the one or more nucleotides in the oligonucleotide probe via a linker.

18. The method of claim 10 wherein the spatially distinct nucleic acid structure is connected to the one or more nucleotides in the oligonucleotide probe by a cleavable nucleotide.

19. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

imaging the single stranded nucleic acid having an oligonucleotide probe hybridized thereto, wherein the single stranded nucleic acid is straightened, wherein the oligonucleotide probe includes a spatially distinct nucleic acid structure corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure, and

identifying the spatially distinct nucleic acid structure, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

20. The method of claim 19 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and 100 hybridizable nucleotides.

21. The method of claim 19 wherein the spatially distinct nucleic acid structure comprises one or more detectable moieties or barcodes.

22. The method of claim 21 wherein the detectable moieties or barcodes correspond to the one or more nucleotides in the oligonucleotide probe.

23. The method of claim 21 wherein the detectable moieties or barcodes comprise fluorescent moieties.

24. The method of claim 19 wherein the spatially distinct nucleic acid structure comprises a substantially circular structure.

25. The method of claim 19 wherein the spatially distinct nucleic acid structure is attached to the one or more nucleotides in the oligonucleotide probe via a linker.

26. The method of claim 19 wherein the spatially distinct nucleic acid structure is connected to the one or more nucleotides in the oligonucleotide probe by a cleavable nucleotide.

27. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

hybridizing an oligonucleotide probe having a spatially distinct nucleic acid corresponding to one or more nucleotides in the oligonucleotide probe, wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure, wherein the oligonucleotide probe is ligated to a sequencing primer hybridized to the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probe hybridized thereto, and

identifying the spatially distinct nucleic acid, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

28. The method of claim 27 wherein the single stranded nucleic acid is straightened.

29. The method of claim 27 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

30. The method of claim 27 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

31. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

hybridizing a plurality of oligonucleotide probes along the single stranded nucleic acid, an oligonucleotide probe of the plurality of oligonucleotide probes having a spatially distinct nucleic acid corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

32. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

hybridizing an oligonucleotide probe having a spatially distinct nucleic acid corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure,

ligating the oligonucleotide probe to a sequencing primer hybridized to the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probe hybridized and ligated thereto, and

identifying the spatially distinct nucleic acid, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

33. The method of claim 32 further including hybridizing a plurality of oligonucleotide probes along the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

34. The method of claim 32 wherein the single stranded nucleic acid is straightened.

35. The method of claim 32 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

36. The method of claim 32 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

37. The method of claim 32 further comprising

straightening the single stranded nucleic acid having the oligonucleotide probe hybridized and ligated thereto.

38. The method of claim 37 further including hybridizing a plurality of oligonucleotide probes along the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

39. The method of claim 37 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

40. The method of claim 37 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

41. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

hybridizing an oligonucleotide probe having a spatially distinct nucleic acid corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure,

straightening the single stranded nucleic acid having the oligonucleotide probe hybridized thereto,

imaging the single stranded nucleic acid having the oligonucleotide probe hybridized thereto, and

identifying the spatially distinct nucleic acid, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

42. The method of claim 41 further including hybridizing a plurality of oligonucleotide probes along the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

43. The method of claim 41 wherein the oligonucleotide probe is ligated to a sequencing primer hybridized to the single stranded nucleic acid.

44. The method of claim 41 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

45. The method of claim 41 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

46. A method for determining the sequence of nucleotides in a single stranded nucleic acid comprising:

straightening the single stranded nucleic acid,

hybridizing to the single stranded nucleic acid an oligonucleotide probe having a spatially distinct nucleic acid corresponding to one or more nucleotides in the oligonucleotide probe wherein the spatially distinct nucleic acid structure is a DNA origami folded in two-dimensional or three-dimensional structure,

imaging the single stranded nucleic acid having the oligonucleotide probe hybridized thereto, and

identifying the spatially distinct nucleic acid, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

47. The method of claim 46 further including hybridizing a plurality of oligonucleotide probes along the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

48. The method of claim 46 wherein the oligonucleotide probe is ligated to a sequencing primer hybridized to the single stranded nucleic acid.

49. The method of claim 46 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

50. The method of claim 46 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

51. The method of claim 46 further comprising

ligating the oligonucleotide probe to a sequencing primer hybridized to the single stranded nucleic acid.

52. The method of claim 51 further including hybridizing and ligating a plurality of oligonucleotide probes along the single stranded nucleic acid,

imaging the single stranded nucleic acid having the oligonucleotide probes hybridized and ligated thereto, and

identifying the spatially distinct nucleic acid structures, the corresponding one or more nucleotides in the oligonucleotide probe and a complementary one or more nucleotides in the single stranded nucleic acid.

53. The method of claim 51 wherein the oligonucleotide probe is a nucleic acid sequence having between about 1 and about 100 hybridizable nucleotides.

54. The method of claim 51 wherein the spatially distinct nucleic acid structure includes a detectable label corresponding to the one or more nucleotides of the hybridized oligonucleotide probe and the detectable label is detected.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2015
From: CHURCH, GEORGE M.; TERRY, RICHARD C.; VIGNEAULT, FREDERIC
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 035591/0482 →
CONFIRMATORY LICENSE Recorded Feb 27, 2015
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035108/0981 →
Continuity (2)
Provisional Application 61655528 · Jun 5, 2012
Related Publication 20150292007A1 · Oct 15, 2015